Testosterone cypionate
- Generic Name
- Testosterone cypionate
- Brand Names
- Depo-testosterone
- Drug Type
- Small Molecule
- Chemical Formula
- C27H40O3
- CAS Number
- 58-20-8
- Unique Ingredient Identifier
- M0XW1UBI14
- Background
Testosterone cypionate is a synthetic derivative of testosterone in the form of an oil-soluble 17 (beta)-cyclopentylpropionate ester. Its benefit compared to other testosterone derivatives is the slow rate of release after injection and longer half-life. It was developed by the company Pharmacia and Upjohn and FDA approved on July 25, 1979.
- Indication
Testosterone cypionate is used in males that present conditions derived from a deficiency or absence of endogenous testosterone. These conditions are 1) primary hypogonadism, defined as the testicular failure due to cryptorchidism, bilateral torsion, orchitis, vanishing testis syndrome or orchidectomy; and 2) hypogonadotropic hypogonadism characterized by idiopathic gonadotropin, LHRH deficiency or pituitary-hypothalamic injury from tumors, trauma or radiation.
- Associated Conditions
- Hypergonadotropic Hypogonadism, Hypogonadotrophic Hypogonadism
- Associated Therapies
- -
Bipolar Androgen Therapy: Rationale, Candidate Patients, and Latest Evidence for mCRPC Patients
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.